Cancer, infectious diseases, and metabolic and hereditary genetic disorders are a global
health burden affecting millions of people, with contemporary treatments offering limited …

Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron (MN) disease. Its primary
cause remains elusive, although a combination of different causal factors cannot be ruled …

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease, for which
no effective treatment is yet available to either slow or terminate it. Recent advances in gene …

Astrocytes play a number of key functions in health and disease. Activated astrocytes are
present in most, if not all, neurological diseases. Most current information on the …

The drug edaravone (EDA) is prescribed for the treatment of patients with amyotrophic
lateral sclerosis or after an acute cerebral infarction. This synthetic pyrazolone derivative is a …

Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease affecting the
upper and lower motor neurons in the motor cortex and spinal cord. Abnormal accumulation …

Amyotrophic lateral sclerosis (ALS) is now recognised to be a heterogeneous
neurodegenerative syndrome of the motor system and its frontotemporal cortical …

Amyotrophic lateral sclerosis (ALS), commonly termed as motor neuron disease (MND) in
UK, is a chronically lethal disorder among the neurodegenerative diseases, meanwhile. ALS …

Amyotrophic lateral sclerosis (ALS) is a lethal progressive neurodegenerative disease,
characterized by a loss of function of upper and lower motor neurons. This study aimed to …

Aims Intravenous high‐dose free methylprednisolone (MP) hemisuccinate is the primary
treatment for an acute relapse in relapsing–remitting multiple sclerosis. However, it is …